Abbott Laboratories (ABT) Competitors $114.23 +1.81 (+1.61%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends ABT vs. ISRG, SYK, BSX, MDT, BDX, EW, IDXX, RMD, DXCM, and STEShould you be buying Abbott Laboratories stock or one of its competitors? The main competitors of Abbott Laboratories include Intuitive Surgical (ISRG), Stryker (SYK), Boston Scientific (BSX), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), and STERIS (STE). These companies are all part of the "health care equipment" industry. Abbott Laboratories vs. Intuitive Surgical Stryker Boston Scientific Medtronic Becton, Dickinson and Company Edwards Lifesciences IDEXX Laboratories ResMed DexCom STERIS Abbott Laboratories (NYSE:ABT) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, community ranking, valuation, risk, profitability, media sentiment, analyst recommendations, earnings and institutional ownership. Does the media prefer ABT or ISRG? In the previous week, Abbott Laboratories had 1 more articles in the media than Intuitive Surgical. MarketBeat recorded 12 mentions for Abbott Laboratories and 11 mentions for Intuitive Surgical. Intuitive Surgical's average media sentiment score of 0.96 beat Abbott Laboratories' score of 0.88 indicating that Intuitive Surgical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abbott Laboratories 7 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Intuitive Surgical 4 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Is ABT or ISRG more profitable? Intuitive Surgical has a net margin of 28.51% compared to Abbott Laboratories' net margin of 13.99%. Abbott Laboratories' return on equity of 20.18% beat Intuitive Surgical's return on equity.Company Net Margins Return on Equity Return on Assets Abbott Laboratories13.99% 20.18% 10.84% Intuitive Surgical 28.51%13.41%11.83% Does the MarketBeat Community prefer ABT or ISRG? Intuitive Surgical received 110 more outperform votes than Abbott Laboratories when rated by MarketBeat users. However, 69.70% of users gave Abbott Laboratories an outperform vote while only 69.09% of users gave Intuitive Surgical an outperform vote. CompanyUnderperformOutperformAbbott LaboratoriesOutperform Votes93469.70% Underperform Votes40630.30% Intuitive SurgicalOutperform Votes104469.09% Underperform Votes46730.91% Which has higher valuation and earnings, ABT or ISRG? Abbott Laboratories has higher revenue and earnings than Intuitive Surgical. Abbott Laboratories is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAbbott Laboratories$41.22B4.81$5.72B$3.2934.73Intuitive Surgical$7.87B23.87$1.80B$6.2284.77 Do analysts recommend ABT or ISRG? Abbott Laboratories presently has a consensus target price of $130.71, suggesting a potential upside of 14.41%. Intuitive Surgical has a consensus target price of $554.17, suggesting a potential upside of 5.11%. Given Abbott Laboratories' higher possible upside, equities analysts plainly believe Abbott Laboratories is more favorable than Intuitive Surgical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Abbott Laboratories 0 Sell rating(s) 4 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.73Intuitive Surgical 1 Sell rating(s) 3 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 2.74 Do insiders & institutionals believe in ABT or ISRG? 75.2% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 83.6% of Intuitive Surgical shares are owned by institutional investors. 1.1% of Abbott Laboratories shares are owned by company insiders. Comparatively, 0.8% of Intuitive Surgical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has more risk and volatility, ABT or ISRG? Abbott Laboratories has a beta of 0.73, indicating that its stock price is 27% less volatile than the S&P 500. Comparatively, Intuitive Surgical has a beta of 1.38, indicating that its stock price is 38% more volatile than the S&P 500. SummaryIntuitive Surgical beats Abbott Laboratories on 11 of the 18 factors compared between the two stocks. Ad Porter & CompanyFirst JFK… next Elon?Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.I share with you in this special investigative documentary. Get Abbott Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ABT vs. The Competition Export to ExcelMetricAbbott LaboratoriesPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$198.16B$6.62B$5.03B$19.22BDividend Yield1.95%3.09%4.87%3.55%P/E Ratio34.7310.60135.5541.13Price / Sales4.81196.561,116.9717.41Price / Cash17.9457.1640.6621.28Price / Book5.115.124.765.33Net Income$5.72B$151.51M$118.46M$988.53M7 Day Performance0.76%-2.03%-1.84%-3.38%1 Month Performance-1.45%-2.99%12.23%-2.25%1 Year Performance6.38%13.79%31.52%14.06% Abbott Laboratories Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ABTAbbott Laboratories4.9055 of 5 stars$114.23+1.6%$130.71+14.4%+6.4%$198.13B$41.22B34.72114,000Dividend IncreaseHigh Trading VolumeISRGIntuitive Surgical4.6662 of 5 stars$546.64+1.3%$550.28+0.7%+61.1%$194.70B$7.87B86.7513,676Analyst ForecastSYKStryker4.9648 of 5 stars$374.95+0.1%$404.35+7.8%+26.5%$142.94B$21.97B40.1852,000Analyst ForecastPositive NewsBSXBoston Scientific4.3943 of 5 stars$91.13+1.1%$95.52+4.8%+61.8%$134.31B$15.91B75.0248,000Analyst ForecastMDTMedtronic4.9289 of 5 stars$82.04-0.5%$95.27+16.1%+0.5%$105.20B$33.00B25.1495,000Analyst ForecastOptions VolumeBDXBecton, Dickinson and Company4.9003 of 5 stars$230.50+2.2%$283.50+23.0%-5.1%$66.64B$20.18B37.9774,000Analyst DowngradeInsider TradeAnalyst RevisionEWEdwards Lifesciences3.918 of 5 stars$73.84+0.7%$79.40+7.5%+0.9%$43.55B$6.00B10.7419,800IDXXIDEXX Laboratories4.9817 of 5 stars$433.37+0.3%$539.63+24.5%-23.6%$35.49B$3.84B41.6711,000RMDResMed4.5175 of 5 stars$241.36+1.2%$227.91-5.6%+36.4%$35.43B$4.81B31.599,980Positive NewsDXCMDexCom4.9076 of 5 stars$76.38-1.0%$98.00+28.3%-31.4%$29.83B$3.95B46.229,600STESTERIS4.9332 of 5 stars$213.74-0.2%$262.50+22.8%-3.5%$21.10B$5.14B48.9118,179Positive News Related Companies and Tools Related Companies ISRG Alternatives SYK Alternatives BSX Alternatives MDT Alternatives BDX Alternatives EW Alternatives IDXX Alternatives RMD Alternatives DXCM Alternatives STE Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:ABT) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abbott Laboratories Please log in to your account or sign up in order to add this asset to your watchlist. Share Abbott Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
